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It is assumed that acute myocardial infarction affects renal
function. To study the mechanism, we used mice following
permanent ligation of their left coronary artery that results in
extensive myocardial infarction. Soon after ligation, there
was a marked rise in circulating pro-inflammatory cytokines
and malondialdehyde (thiobarbituric acid-positive evidence
of lipid peroxidation). Renal function had significantly
declined by the third day in association with mild fibrosis,
and swelling of glomeruli and tubules. There was a
significant increase in the expression of the lectin-like
oxidized low-density lipoprotein receptor-1 (LOX-1),
interelukin-1b, vascular cell adhesion molecule-1, and
thiobarbituric acid-reactive substances in the kidney. Renal
function showed some recovery by Day 21; however, there
was progressive fibrosis of the kidneys. LOX-1 knockout mice
had significantly diminished increases in systemic and renal
pro-inflammatory cytokines, malondialdehyde, structural
alterations, and decline in renal function than the wild-type
mice following ligation of the left coronary artery. Cardiac
function and survival rates were also significantly better in
the LOX-1 knockout mice than in the wild-type mice. Hence,
severe myocardial ischemia results in renal dysfunction and
histological abnormalities suggestive of acute renal injury.
Thus, LOX-1 is a key modulator among multiple mechanisms
underlying renal dysfunction following extensive myocardial
infarction.
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Myocardial ischemia is the most common cause of mortality
and morbidity in the developed countries and is rapidly
becoming a common malady in the developing countries.
Patients who survive acute myocardial infarction often
develop cardiac functional impairment, which if sustained
affects the kidneys. This has been addressed as cardiorenal
syndrome. The simplistic view of cardiorenal syndrome is
that a relatively normal kidney becomes dysfunctional
because of sustained low cardiac output. This concept has
been recently challenged, and a more articulated definition of
cardiorenal syndrome has been presented.1 This includes a
variety of acute or chronic conditions where the primary
failing organ can be either the heart or the kidney.1 Thus,
direct and indirect effects of each organ that is dysfunctional
can initiate and perpetuate the combined disorder of the two
organs through a complex combination of neurohormonal
feedback mechanisms.1–3
There is a link between coronary heart disease and renal
dysfunction, which may be a manifestation of endothelial/
epithelial dysfunction leading to the syndrome of migration
of oxidized lipids through the inter-endothelial junctions to
the intima (atherogenesis) and to passage of plasma proteins
(microalbuminuria) through the inter-epithelial junctions.4
It has been suggested that the abnormalities in renin–angio-
tensin system and oxidized low-density lipoproteins (ox-
LDL) participate in the pathogenesis of this process through
expression and activation of a lectin-like receptor LOX-1 in
the heart and the kidney.4
Clinicians have suggested a renal functional defect during
the acute phase of myocardial infarction, and attributed renal
dysfunction to low cardiac output state and/or marked
increase in venous pressure leading to kidney congestion.1,5
However, direct evidence for this phenomenon has not
been presented. Nonetheless, it is well known that worsening
renal function following myocardial infarction is a powerful
and independent predictor of in-hospital and 1-year
mortality.6,7
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A plausible basis for this independent effect might be that
an acute decline in renal function during myocardial infarction
does not merely reflect severity of the illness, but involves
complex cardiovascular pathobiology mediated through
activation of inflammatory pathways.8,9 Acute myocardial
infarction is associated with a systemic pro-inflammatory and
pro-oxidant state. The activation of renin–angiotensin system
contributes to this pro-inflammatory and pro-oxidant state in
the injured myocardium. Renin–angiotensin system activation,
especially when sustained, has been shown to induce fibroblast
growth and cardiomyocyte hypertrophy via activation of
angiotensin II type 1 receptor.
Our studies have shown that the pro-inflammatory and
pro-oxidant state in the hearts of rats and mice subjected to
acute myocardial ischemia is accompanied by a marked
upregulation of LOX-1.10,11 LOX-1 is a pro-inflammatory
molecule that is responsible for polymorphonuclear leuko-
cyte (PMNL) accumulation in the ischemic and injured
tissues.12,13 Expression and activation of LOX-1 also result in
the release of oxidant species.14,15 The key evidence in favor
of the pathogenic role of LOX-1 expression/activation came
from studies wherein an antibody given before induction of
myocardial ischemia reduced inflammatory and oxidant
response and resultant injury to the heart.16 Hu et al.17
showed that mice with LOX-1 deletion (termed LOX-1
knockout or KO) have significantly less myocardial injury
following coronary ligation than do wild-type (WT) mice
subjected to the same degree of ischemia.
We hypothesized that the systemic inflammatory process
present during and following acute myocardial infarction
may affect renal function. We also posited that LOX-1
abrogation would limit renal dysfunction following myocar-
dial infarction by inhibiting pro-inflammatory and pro-
oxidative signaling.
RESULTS
Survival after total left coronary artery ligation
The survival rates in WTand LOX-1 KO mice that underwent
sham left coronary artery (LCA) ligation for 3 weeks were
comparable. On Day 3 post-LCA ligation, 79% of the LOX-1
KO mice survived (vs. 58% of WTmice, Po0.05). LOX-1 KO
mice had 25% improvement in survival over the WT mice
over the 3-week period following LCA ligation. These data
are similar to another report from our laboratory in a
different group of mice.18
Heart weight after LCA ligation
The heart weight/tibia length ratio, an indicator of cardiac
hypertrophy, was increased in both groups of mice subjected
to LCA ligation. The increase in the heart weight/tibia
length was less in the LOX-1 KO group (P¼ 0.001 vs. WT
mice; Table 1).
Left ventricular function after LCA ligation
There was a significant suppression of LV function as assessed
by echocardiography on Day 3 as well as on Day 21 post-LCA
ligation in the WT mice (P¼ 0.001. vs. sham ischemia
WT mice; Figure 1). On Day 21, there was significant
dilation of LV and thinning of LV anterior wall. Notably, LV
function showed less deterioration in the LOX-1 KO
mice subjected to LCA ligation on Day 3 as well as Day 21
(vs. WT mice) (Figure 1).
Arterial pressure after LCA ligation
Basal blood pressure was similar in the WT and LOX-1 KO
mice and remained unchanged in all sham ischemia mice.
Systolic blood pressure was lower in WT and LOX-1 KO mice
during the 3-week period after LCA ligation than in
corresponding groups of sham ischemia mice (Po0.05).
Although the systolic blood pressure was slightly lower in WT
mice with LCA ligation compared with LOX-1 KO mice, the
difference was not significant (Figure 2).
Renal function after LCA ligation
As shown in Figure 2, serum creatinine and glomerular
filtration rate (GFR) values were comparable and remained
within the normal range in the WT and LOX-1 KO mice
subjected to sham LCA occlusion. There was, however, a
significant decline in GFR and rise in serum creatinine and
blood urea nitrogen (BUN) on Day 3 in the WT mice with
LCA ligation. In contrast, the decline in GFR and rise in
serum creatinine were much less in the LOX-1 KO mice
(P¼ 0.001).
On Day 21, there was a significant improvement in GFR
and in serum creatinine and BUN in the WTmice with LCA
ligation, although the values were still in the abnormal range.
Table 1 | The organ gravimetric parameters
Parameters
WT ischemia
(sham)
LOX-1 KO
ischemia (sham)
WT ischemia
(3 days)
LOX-1 KO
ischemia (3 days)
WT ischemia
(3 weeks)
LOX-1 KO ischemia
(3 weeks)
Body weight (g) 25.75±1.55 25.38±1.82 22.31±1.90 23.87±1.24 26.29±2.23 26.49±3.02
Heart weight (mg) 123±5.40 126±6.10 157±6.20* 135±7.03z 179±7.30* 155±7.72*,z
Heart weight per
tibia length (mg/mm)
7.00±0.15 7.10±0.20 9.13±0.76* 7.94±0.71z 10.91±1.03* 8.8±0.68*,z
1-Kidney weight (mg) 167±5.20 165±4.55 232±8.34* 187±9.47*,z 227±7.69* 178±7.32*,z
1-Kidney weight per
body weight (mg/g)
7.10±0.21 7.06±0.19 9.33±0.86* 7.79± 0.53z 8.76±0.95* 7.54±0.38z
Abbreviations: KO, knockout; LOX-1, low-density lipoprotein receptor-1; WT, wild type.
N=6 male mice in each group. Data are expressed as mean±s.d.
*Po0.05 compared to corresponding sham ischemia group.
zPo0.05 compared to WT mice.
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In contrast, serum BUN and creatinine and GFR values were
in the normal range on Day 21 after LCA ligation in the LOX-
1 KO mice (Po0.05 vs. WT mice with LCA ligation).
Renal morphology in mice with LCA ligation
The kidney weight was markedly increased on Day 3 in both
groups of mice subjected to LCA ligation (Po0.05 vs. kidney
weight in respective groups of mice subjected to sham
ischemia), but the increase was less in the LOX-1 KO mice
(Po0.05 vs. WT mice; Figure 3a). Kidney weight on Day 21
post-LCA ligation was less than on Day 3, although still more
than in the corresponding groups of mice subjected to sham
ischemia. These data are summarized in Table 1.
There were striking changes in the morphology of kidneys
from WTand LOX-1 mice subjected to LCA ligation. On Day
3 post-LCA ligation, there was marked swelling of the
glomeruli and tubules, and an extensive presence of casts in
the tubules in the WT mice (Figure 3b). There was a
small amount of fibrosis throughout the medulla in the
periglomerular and perivascular regions (Figure 4). Further,
there was accumulation of PMNLs throughout the kidney
on Day 3 post-LCA occlusion in the WT mice, and the
accumulation of PMNLs was much less in the LOX-1 KO
mice. Representative examples are shown in Figure 3b, and
the summary of data is presented in Figure 3d. Expression of
pro-inflammatory molecules, pro-interelukin-1b (IL-1b),
vascular cell adhesion molecule-1 (VCAM-1), and tumor
growth factor-b1 (TGF-b1), was increased markedly on Day
3 after LCA ligation in the kidneys of WT mice (Po0.05;
Figure 3c and Supplementary Figure S3 online); the LOX-1
KO mice had a much smaller increase in pro-IL-1b, VCAM-1,
and TGF-b1 expression (Po0.05 vs. WT mice).
On Day 21 post-LCA ligation, the swelling of glomeruli
and tubules was less as was the presence of casts in the
tubules as compared with Day 3 post-LCA ligation. However,
fibrosis was more extensive (Figure 4a–c), and it was present
in the periglomerular and perivascular regions, and also in-
between tubules. Changes in glomeruli, tubules, and the
extent of fibrosis were qualitatively similar in the WT and
LOX-1 KO mice, but quantitatively less marked in the LOX-1
KO mice (Po0.05).
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Figure 1 |Representative M-mode echocardiography tracings and summary data. Shown are the data on ejection fraction, left
ventricular (LV) anterior wall systolic thickness, and LV internal diameter in end-diastole in the wild-type (WT) and low-density lipoprotein
receptor-1 (LOX-1) knockout (KO) group at Days 3 and 21 (3 weeks) after total left coronary artery (LCA) ligation. Note that the changes were
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Figure 2 |Renal function and blood pressure following left
coronary artery (LCA) occlusion measured as glomerular
filtration rate (GFR), serum blood urea nitrogen (BUN), and
creatinine. Note that the blood pressure was similar in wild-type
(WT) and lipoprotein receptor-1 (LOX-1) knockout (KO) mice at
all time points. Data, shown as mean±s.d., are based on
measurements in 8–10 animals in each group. *Po0.05 vs.
corresponding sham ischemia group; zPo0.05 vs. WT group; n¼ 6.
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Figure 3 |Kidney weight and inflammation following left coronary artery (LCA) ligation. (a) Representative pictures of kidneys from
the wild-type (WT) and lipoprotein receptor-1 (LOX-1) knockout (KO) groups. The lower panel shows summary data, shown as mean±s.d.,
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subjected to total LCA ligation. (b) Renal histology shows polymorphonuclear leukocytes (PMNLs) in the peritubular regions (original
magnification  600). In contrast to WT mice, the number of PMNLs was much less in the LOX-1 KO mice. (c) Representative protein
expression of interleukin-1b (IL-1b), vascular cell adhesion molecule-1 (VCAM-1), and tumor growth factor-b1 (TGF-b1) in the mice kidneys.
(d) Quantification of accumulation of PMNLs. H.p.f.: high power field. At least 100 glomeruli and tubules were examined in each slice, and at
least four slices were examined in each kidney and the data averaged. *Po0.05 compared to corresponding sham ischemia; zPo0.05
compared to WT groups subjected to total LCA ligation.
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Figure 4 |Accelerated fibrosis in the kidney after prolonged myocardial ischemia. (a) Representative sections of kidney stained with
Masson’s trichrome (original magnification  200) after left coronary artery (LCA) ligation. (b) Kidney section using Masson’s trichrome
staining (original magnification  600) revealed less tubulointerstitial fibrosis and glomerulosclerosis in the lipoprotein receptor-1 (LOX-1)
knockout (KO) mice at Day 3 after LCA occlusion. (c) Summary data, shown as mean±s.d., on the area of collagen deposition in the kidneys
of WT and LOX-1 KO mice. At least four slices were examined in each kidney and summary data were obtained from six mice in each group.
*Po0.05 compared to corresponding sham ischemia group; zPo0.05 compared to WT chronic ischemia. (d) Representative western blots of
fibrosis-related proteins (collagen IV-a2 and procollagen-1) and b-actin expression.
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Markers of collagen formation in the kidney
Molecular markers of collagen formation (collagen IV-a2 and
procollagen-I) were increased in the renal tissue of WT mice
on Day 3 post-LCA ligation, and the increase in these
markers persisted on Day 21. Increase in the markers of
collagen formation was much less in the LOX-1 KO mice
despite the same site of LCA ligation (Figure 4d).
Assessment of systemic inflammatory state
Pro-inflammatory cytokines, IL-1b, IL-6, interferon-g, and
tumor necrosis factor-a (TNF-a), as well as immunomodu-
latory cytokines, IL-10, were measured during the first 3 days
post-LCA ligation. Serum levels of IL-1b, IL-6, and TNF-a
were markedly elevated in the WT mice with peak at 24 h,
followed by a steady decline to normal level by 72 h. The
increase in pro-inflammatory and immunomodulatory
cytokines was less in the LOX-1 KO mice (P¼ 0.001 vs.
WT mice; Figure 5).
Assessment of pro-oxidant state and collagen markers in the
kidney
On Day 3 post-LCA ligation, there was a significant increase
in the serum malondialdehyde and the kidney thiobarbituric
acid-reactive substances in the WT mice; again, the increase
in the serum malondialdehyde and the kidney thiobarbituric
acid-reactive substances was less pronounced in the LOX-1
KO mice (Po0.05). The pro-oxidant state declined modestly
in both groups on Day 21 (Figure 6a and b).
LOX-1 was expressed in the kidneys only modestly at
baseline (sham ischemia group), and its expression increased
markedly following LCA ligation in the WT mice. As
expected, there was no LOX-1 in the LOX-1 KO mice either
before or after LCA ligation (Figure 6c and d).
Increase in LOX-1 in the WT mice was associated with
enhanced phosphorylation of IkBa (Po0.05 vs. sham
ischemia group). The activation of IkBa protein was less
pronounced in the LOX-1 KO mice kidneys (P¼ 0.001 vs.
WT mice) (Figure 6c and d).
DISCUSSION
This study presents novel data on the development of renal
dysfunction in mice that had been subjected to total and
permanent LCA ligation. On Day 3 post-LCA ligation, there
was marked glomerular and tubular swelling and extensive
deposits of cast in the tubular lumen, and minimal, but
definite, evidence of fibrosis and activation of markers of
collagen formation. Further, there was a significant decrease
in GFR and a marked rise in serum BUN and creatinine,
indicating renal dysfunction. These observations on renal
dysfunction and altered morphology are reminiscent of acute
renal injury seen in extensive tissue ischemia, trauma, or
infection. On Day 21 after LCA ligation, renal function had
improved compared to Day 3. The observations of some
improvement in renal function at 3 weeks post-myocardial
infarction are consistent with the natural history of acute
renal injury. However, there was evidence of ongoing fibrosis
in the kidneys at this time point when the LV was dilated, and
cardiac remodeling had set in.
The acute deterioration in renal function identified soon
after LCA ligation was associated with a rise in serum
markers of inflammation (IL-1b, IL-6, TNF-a, and inter-
feron-g), suggesting a state of systemic inflammation. There
was also evidence of inflammation in the kidney as the
expression of several pro-inflammatory molecules, pro-IL-
1b, IL-1b, and VCAM-1, was increased and there was
evidence of PMNL infiltration in the renal tissues. Although
the generalized inflammatory state following myocardial
infarction has been known for quite some time,10 the
evidence for inflammatory state in the kidney has not been
presented thus far.
We suggest that the alterations in renal function and
morphology, including fibrosis, are a direct result of a
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Figure 5 | Serum concentration of pro-inflammatory cytokines during the first 3 days after left coronary artery (LCA) ligation.
Summary data, shown as mean±s.d., from six mice in each group. zPo0.05 vs. WT group. GM-CSF, granulocyte–macrophage colony-
stimulating factor; IFN, interferon; IL, interleukin; KO, knockout; TNF, tumor necrosis factor; WT, wild type.
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systemic inflammatory state following significant myocardial
ischemia. In keeping with our postulate, Fujiu et al.19 have
recently reported the association of inflammation and
fibrosis in the kidney.
Previous studies from our laboratory showed overexpres-
sion of LOX-1 in the myocardium following a brief period of
ischemia.10,20 Acute ischemia is associated with activation of
renin–angiotensin system and generation of large amounts
of angiotensin II and expression of its type 1 receptor.18
Activation of angiotensin type 1 receptor activates NADPH
oxidases in various tissues and circulating cells.21,22 The
NADPH oxidase system is perhaps the most potent reactive
oxygen species-generating system in vascular tissues. Reactive
oxygen species are known to be potent pro-inflammatory and
tissue injurious molecules.23 Other recent studies from our
laboratory18 show that total and permanent LCA ligation
similar to the one used in this study results in a sustained
activation of LOX-1-NADPH oxidase-inflammation cascade
in the myocardium. These observations suggest an important
relationship between oxidant stress and inflammation. It is of
note that reactive oxygen species per se can induce LOX-1
expression.24–26 There is also an important role for redox-
sensitive transcription factors, such as nuclear factor-kB (NF-
kB), in reactive oxygen species-mediated inflammation.25
Activation of NF-kB promotes the expression of pro-
inflammatory cytokines, such as TNF-a and IL-6.
LOX-1 itself can serve as a pro-inflammatory adhesion
molecule,27 and its expression and activation can lead to
reactive oxygen species generation.27,28 In this study, we
found that the levels of oxidation and inflammatory markers
in the serum and the kidney were elevated in the WT mice
after LCA occlusion, and the rise in levels of these markers
was much less marked in the LOX-1 KO mice.
It is intriguing that LOX-1 expression increased in the
kidneys of WTmice subjected to LCA ligation without direct
injury to the kidney. The blood pressure fell soon after LCA
ligation as a result of myocardial dysfunction. It is possible
that the pattern of injury identified in this study is a
reflection of ‘hemodynamic shock’ to the kidneys. However,
the decline in blood pressure was only modest and similar in
both WT and LOX-1 KO mice, suggesting that the decline in
blood pressure is not the sole etiology of deterioration of
renal function and extensive pathological alterations in the
renal tissues. The pattern of renal dysfunction and injury
improved over the 3 weeks following LCA ligation, indicated
by an improvement in renal function and morphology.
However, there was progressive fibrosis in renal tissues in the
WTmice and deterioration in LV function at this time point.
It is likely that the interaction between oxidant stress,
angiotensin II, and LOX-1 is responsible for growth and
activation of fibroblasts and generation of collagen. Chen
et al.29–31 showed that collagen formation by fibroblasts can
be reduced by treatment with angiotensin II type 1 receptor
blockers, peroxisome proliferator-activated receptor-g
ligands, and LOX-1 antibody. In the kidneys of mice
with chronic LCA ligation, there was increased expression
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of TGF-b1, a potent inducer of fibrosis. Hu et al.32 showed a
cross-talk between TGF-b1 and LOX-1 with a critical
interactive role of reactive oxygen species, mitogen-activated
protein kinases, and NF-kB in this cross-talk. In keeping with
the hypothesis of a cross-talk between TGF-b1, reactive oxygen
species, and LOX-1, there was much more TGF-b1 expression
in the renal tissues of WT mice compared with LOX-1 KO
mice, both subjected to total and permanent LCA ligation.
This study shows that following LCA ligation and
extensive myocardial necrosis, there was intense collagen
deposition in the kidney, presumably as a result of
inflammation and oxidant stress resulting in fibroblast
growth and activation. There was a significant alteration in
the expression of NF-kB regulator IkBa. The alterations in
renal morphology and function were much less in the kidneys
of LOX-1 KO mice Day 3 as well as on Day 21 post-LCA
occlusion, indicating a prominent role for LOX-1 in collagen
synthesis and its deposition in the kidney after prolonged and
extensive myocardial ischemia.
Kelly et al.33 identified LOX-1 expression in the proximal
tubules in 32-week-old obese rats with uncontrolled diabetes
and dyslipidemia. Dominguez et al.34 from the same
laboratory showed that inhibition of LOX-1 with a binding
antibody can effectively reverse critical pathogenic elements
of nephropathy in the obese ZS rats with diabetes and
dyslipidemia. Their study showed that blockade of LOX-1
limits renal lipotoxicity, inflammation, and peritubular
fibrosis. In keeping with these findings, Hu et al.26 observed
extensive areas of fibrosis in the kidney of WTmice subjected
to angiotensin II infusion for 4 weeks; importantly, renal
fibrosis and dysfunction was reduced by LOX-1 abrogation
despite angiotensin II infusion. These investigators also
indicated that the state of oxidant stress and inflammation
is the basis of fibroblast growth and collagen accumulation in
the kidney and deterioration of renal function.
In this study, we have shown a pathogenic role of LOX-1 in
the determination of LV dysfunction in keeping with another
study in a separate group of animals.18 LOX-1 abrogation
attenuated systemic inflammation, reactive oxygen species
generation, and IkBa activation in the kidney. Importantly,
the LOX-1 KO mice showed less PMNL accumulation,
glomerular/interstitial damage, and fibrosis in the kidney
despite similar degree and duration of myocardial ischemia.
It is possible that preserved renal function and morphology
in these mice relates to improved cardiac function, but the
limitation of inflammation and oxidant stress by LOX-1
deletion perhaps played a more significant role.
Important questions that arise from this study and will
need to be addressed in future studies are: (1) Are there are
other mediators of renal injury during myocardial infarction
besides systemic inflammatory cytokine release and a ‘shock-
like state’? In this context, expression of endothelin-1 in the
kidney may be of interest as this cytokine is a potent
vasoconstrictor and can reduce GFR, is NF-kB-dependent,
and oxidant-inducible; (2) What is the fate and long-term
functional consequences of renal fibrosis? (3) What is the
appropriate therapy of acute renal injury that accompanies
extensive myocardial injury?
In summary, we have presented a provocative observation
of renal enlargement, extensive injury, and dysfunction following
extensive myocardial infarction in mice. Since LOX-1 deletion
reduced the markers of renal injury and dysfunction despite
similar site of LCA occlusion, it is tempting to postulate that
the state of generalized inflammation and oxidant stress
following myocardial infarction affects the kidney that
undergoes morphological and functional changes.
MATERIALS AND METHODS
Animal Protocol
C57BL/6 mice (also referred to as wild-type mice) were obtained
from Jackson Laboratories (Bar Harbor, ME). The homozygous
LOX-1 KO mice were developed and backcrossed eight times with
C57BL/6 strain to replace the genetic background as described
previously.35 C57BL/6 and homozygous LOX-1 KO (on C57BL/6
background) mice were bred by brother–sister mating and housed
in a breeding colony. All experimental procedures were performed
in accordance with protocols approved by the Institutional Animal
Care and Use Committee.
Genotyping
LOX-1 genotypes were verified by polymerase chain reaction
analysis of genomic DNA extracted from the tail.
Details of the methodology have been published recently.18
Left coronary artery ligation and determination of left
ventricular function
Animals were anesthetized, intubated, and mechanically ventilated.
Body temperature was maintained between 37.0 1C and 37.5 1C with
a heating pad. After equilibration period of 5min, under aseptic
conditions, left thoracotomy was performed in the 4th intercostal
space and the pericardium opened. A 8-0 silk suture was passed
around the proximal LCA and the LCA totally occluded perma-
nently. This resulted in extensive infarct and LV dysfunction.
Another group of animals underwent the same procedure, but no
LCA ligation (sham ischemia). Additional details of the protocol are
provided elsewhere.18 LV ejection fraction, wall thickness, and
chamber dimensions were measured by echocardiography on Days 3
and 21 after LCA ligation, as described recently.18
Determination of blood pressure
Systolic blood pressure was measured through a tail-cuff apparatus
(AD Instruments, Bella Vista, NSW, Australia) in conscious mice 3
days before and then on days 0, 3, and 21 after LCA ligation. Systolic
blood pressure values were derived from an average of two cycles for
20 measurements per animal at each time point. Three preliminary
training sessions were performed during 1 week before starting the
experiment to ensure accurate measurements. In preliminary
studies, the accuracy of tail cuff was established by comparing data
obtained with biotelemetry system (Data Sciences, St Paul, MN).
Measurement of renal function
GFR in mild anesthetized mice was measured by fluorescein
isothiocyanate-inulin clearance, as described previously,36 and
expressed as microliters of fluorescein isothiocyanate-inulin cleared
per minute. GFR values were corrected for kidney weight. Serum
442 Kidney International (2012) 82, 436–444
or ig ina l a r t i c l e J Lu et al.: Myocardial ischemia and renal dysfunction
creatinine and BUN were determined using the diagnostic kit from
International Bio-Analytical Industries (Boca Raton, FL).
Morphological and histological assessment
Hearts and kidneys were harvested and weighted. Heart weight is
shown as the ratio of tibia length. Kidney weight is shown as the
ratio of kidney weight to body weight (mg/g). Multiple renal
longitudinal sections were stained with hematoxylin–eosin and
Masson’s trichrome. Sections from the entire kidney were analyzed
by an individual blinded to the study groups. PMNLs were counted
in kidney sections stained with hematoxylin–eosin at original
magnification  600. Interstitial fibrosis was assessed in sections
stained with Mason’s trichrome, and the area of interstitial fibrosis
was quantified. At least four slices were examined in each kidney
with six mice in each group.
Determination of oxidative stress
Lipid peroxidation was determined in the renal cortical tissue as
thiobarbituric acid-reactive substances,37 and expressed as micro-
moles per gram wet weight. Malondialdehyde levels were expressed
as mmol/l.38
Assessment of systemic inflammatory state by multiplex
system
To assess the release of chemokines and cytokines in systemic
circulation, the serum was obtained at 24, 48, and 72 h post-surgery.
Chemokines and cytokines were measured by the Bio-Plex Protein
Array System and a mouse cytokine 8-plex panel (Bio-Rad
Laboratories, Hercules, CA), according to the manufacturer’s
instructions. Concentrations of each cytokine were determined using
Bio-Plex Manager software (Bio-Rad). The panel includes the
following cytokines: IL-1b, IL-2, IL-4, IL-6, IL-10, granulocyte–
macrophage colony-stimulating factor, interferon-g, and TNF-a. The
assay range was from 0.2 to 5000 pg/ml.
Western blot analysis
Inflammation-related molecules, LOX-1, IL-1b, and VCAM-1, were
measured in the renal tissues by western blotting. Several collagen-
related signals (collagen IV-a2 and procollagen-1) were also
measured. IkBa and its phosphorylated form, as well as b-actin,
were measured by western blotting. Primary antibodies were
purchased from Santa Cruz Biotechnology (Santa Cruz, CA), Cell
Signaling Technology (Danvers, MA) or Abcam (Cambridge, MA).
Anti-LOX-1 antibody was obtained from Dr T Sawamura. The
densities of protein bands were quantified by Quantity One Image
Analyzer (Bio-Rad), and the band was normalized to that of b-actin.
Statistical analysis
Data are presented as mean±s.d. Mice survival was analyzed by
Kaplan–Meier analysis, and between-groups differences were tested
by the log-rank test. Between-groups means were compared by one-
way analysis of variance, followed by Student–Newman–Keuls test.
A Po0.05 was considered significant.
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